Brentuximab Vedotin with Chemotherapy for Patients with Previously Untreated Stage III/IV Classical Hodgkin Lymphoma: 5-Year Update of the ECHELON-1 Study Ramchandren, R., Dlugosz-Danecka, M., Connors, J. M., Radford, J., Illes, A., Picardi, M., Lech-Maranda, E., Feldman, T., Smolewski, P., Savage, K. J., Bartlett, N. L., Walewski, J., Zinzani, P., Hutchings, M., Munoz, J., Kim, W., Advani, R., Ansell, S. M., Gallamini, A., Alekseev, S., Lee, H., Liu, R., Little, M., Fenton, K., Fanale, M., Straus, D. J. CIG MEDIA GROUP, LP. 2021: S371

View details for Web of Science ID 000691910500287